<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>News Archive</title>
    <link>https://www.dqbm.uzh.ch/en/News-Archive.html</link>
    <description />
    <item>
      <title>The Krauthammer Group Develops Explainable Deep Learning Model for Predicting Disease Activity in Joint Disorders</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Fragmentstein2.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:fa72dffe-ec90-48de-b562-129f1e0e46bf/Trottet_2024_Fig10.PNG" width="90" height="60" />
      <description><![CDATA[<p>See <a href=&quot;https://doi.org/10.1371/journal.pdig.0000422&quot;>Trottet et al., PLOS Digital Health 2024</a></p>

<p>A new study by the Krauthammer group presents DAS-Net, an explainable deep learning model for predicting disease activity in chronic inflammatory joint diseases. This model utilizes patient data to make predictions and identifies similar patients based on disease progression. The approach outperforms traditional models and enhances understanding through feature attribution, providing insights into key patient characteristics impacting disease.</p>]]></description>
      <pubDate>Wed, 26 Jun 2024 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Fragmentstein2.html</guid>
      <dc:date>2024-06-26T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Krauthammer group and collaborators develop advanced AI model to predict disease risk from multimodal data</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Fragmentstein0.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:e7eee54c-17f9-4d81-a6b5-394c5e47a128/Krauthammer_NatBioT_2024.png" width="90" height="60" />
      <description><![CDATA[<p>See <a href=&quot;http://The success of prime editing depends on the prime editing guide RNA (pegRNA) design and target locus. Here, we developed machine learning models that reliably predict prime editing efficiency. PRIDICT2.0 assesses the performance of pegRNAs for all edit types up to 15 bp in length in mismatch repair-deficient and mismatch repair-proficient cell lines and in vivo in primary cells. With ePRIDICT, we further developed a model that quantifies how local chromatin environments impact prime editing rates.&quot;>Mathis et al., Nature Biotechnology 2024</a></p>

<p>The success of prime editing depends on the prime editing guide RNA (pegRNA) design and target locus. Here, we developed machine learning models that reliably predict prime editing efficiency. PRIDICT2.0 assesses the performance of pegRNAs for all edit types up to 15 bp in length in mismatch repair-deficient and mismatch repair-proficient cell lines and in vivo in primary cells. With ePRIDICT, we further developed a model that quantifies how local chrom</p>]]></description>
      <pubDate>Thu, 20 Jun 2024 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Fragmentstein0.html</guid>
      <dc:date>2024-06-20T22:00:00Z</dc:date>
    </item>
    <item>
      <title>In collaboration, the Joller group and the Krauthammer group reveal the regulatory role of tissue-specific Tregs in autoimmune diseases</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Joller_Th1Memory.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:36b4e77c-f3cc-4af8-b28f-da9a9e21a9b3/pnas.2312837121fig01.jpg" width="90" height="60" />
      <description><![CDATA[<p>See&amp;nbsp; <a href=&quot;https://doi.org/10.1073/pnas.2312837121&quot;>Rakebrandt et al.,&amp;nbsp;&amp;nbsp;Proc Natl Acad Sci U S A. 2024</a></p>

<p>The Krauthammer group introduces Fragmentstein, a command-line tool designed to convert non-sensitive cfDNA fragment data into BAM files suitable for standard bioinformatics analyses. This innovative approach facilitates data sharing without compromising sensitive genomic information, enabling analyses like CNV, nucleosome occupancy, and fragment length studies while ensuring data privacy.</p>]]></description>
      <pubDate>Tue, 04 Jun 2024 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Joller_Th1Memory.html</guid>
      <dc:date>2024-06-04T22:00:00Z</dc:date>
    </item>
    <item>
      <title>Bernd Bodenmiller on strategy&amp; Insider Podcast on Harnessing AI for next generation cancer diagnostics</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Bernd-Bodenmiller-on-strategy--Insider-Podcast0.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:73f461ab-0532-48f0-ad4b-1908d23e958e/Strategy&amp;_Episode%2023_Podcast%20visual_1200x1200.png" width="90" height="60" />
      <description><![CDATA[<p>DQBM&amp;#39;s Prof. Dr. Bernd Bodenmiller appears on the latest issue of the <a href=&quot;https://www.strategyand.pwc.com/de/en/insider-podcast.html&quot;>strategy&amp; insider podcast</a>, talking about Harnessing AI for next generation cancer diagnostics. In this episode, Bernd Bodenmiller and Andreas Wicki&amp;nbsp;share their vision to transform cancer diagnosis, treatment, and management through cutting-edge tumor profiling techniques and exploratory research. Tune in and find out about recent developments in cancer research, the power of data and technology &amp;ndash; and how AI can revolutionize precision oncology.</p>

<p>Tune in now on <a href=&quot;https://podcasts.apple.com/de/podcast/strategy-insider-episode-23-harnessing-ai-for-next/id1481851524?i=1000657225474&quot;>Apple Podcasts</a>, <a href=&quot;https://open.spotify.com/episode/7z5OgZHhE6PEvKyzUkuiZw?si=6e8e1a6d792344f4&quot;>Spotify</a>, or&amp;nbsp;<a href=&quot;https://strategyandinsider.podigee.io/23-new-episode&quot;>Podigee</a>.</p>]]></description>
      <pubDate>Wed, 29 May 2024 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Bernd-Bodenmiller-on-strategy--Insider-Podcast0.html</guid>
      <dc:date>2024-05-29T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Krauthammer group develops Fragmentstein: A Novel Tool for cfDNA Fragment Analysis</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Fragmentstein.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:91ce6ecf-8bac-4764-9c61-8b780c4ee3b2/MK_2024_Jan_Balazs.png" width="90" height="60" />
      <description><![CDATA[<p>See <a href=&quot;https://academic.oup.com/bioinformatics/article/40/1/btae017/7550024?login=true&quot;>Bal&amp;aacute;zs et al., Bioinformatics 2024</a></p>

<p>The Krauthammer group introduces Fragmentstein, a command-line tool designed to convert non-sensitive cfDNA fragment data into BAM files suitable for standard bioinformatics analyses. This innovative approach facilitates data sharing without compromising sensitive genomic information, enabling analyses like CNV, nucleosome occupancy, and fragment length studies while ensuring data privacy.</p>]]></description>
      <pubDate>Mon, 01 Jan 2024 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Krauthammer_Fragmentstein.html</guid>
      <dc:date>2024-01-01T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Polymenidou group and collaborators detect TDP-43 seeding activity in the olfactory mucosa of FTD patients</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/TDP-43-seeding-activity-in-the-olfactory-mucosa-of-FTD-patients.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:b958c111-7718-4549-9fda-a88bb21a09d6/alz13541-fig-0004-m.jpg" width="90" height="60" />
      <description><![CDATA[<p>See Fontana and Bongianni et al., <a href=&quot;https://doi.org/10.1002/alz.13541&quot;>Alzheimer&amp;#39;s and Dementia</a></p>

<p>In this work, the Polymenidou group and collaborators assessed TAR DNA-binding protein 43 (TDP-43) seeding activity and aggregates detection in olfactory mucosa of patients with frontotemporal lobar degeneration with TDP-43-immunoreactive pathology (FTLD-TDP) by TDP-43 seeding amplification assay (TDP43-SAA) and immunocytochemical analysis. They demonstrate that TDP-43 aggregates can be detectable in olfactory mucosa, suggesting that their TDP43-Seeding Amplification Assay might be useful for identifying and monitoring FTLD-TDP in living patients.</p>]]></description>
      <pubDate>Mon, 30 Oct 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/TDP-43-seeding-activity-in-the-olfactory-mucosa-of-FTD-patients.html</guid>
      <dc:date>2023-10-30T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group develops an end-to-end multiplexed image processing and analysis workflow</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/An-end-to-end-workflow-for-multiplexed-image-processing-and-analysis..html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:1a4a5f41-a10e-4f5a-8dc1-c28ee323d9ce/Screenshot%202023-10-11%20at%2013.42.00.png" width="90" height="60" />
      <description><![CDATA[<p>See Windhager et al., <a href=&quot;https://doi.org/10.1038/s41596-023-00881-0&quot;>Nature Protocols</a></p>

<p>In this work, the Bodenmiller group&amp;nbsp;presents an end-to-end workflow for multiplexed tissue image processing and analysis that integrates previously developed computational tools to enable image segmentation, feature extraction and spatially resolved single-cell analysis&amp;nbsp;in a user-friendly&amp;nbsp;and customizable way. This protocol can be implemented by researchers with basic bioinformatics training, and the analysis of the provided dataset can be completed within 5&amp;ndash;6 h.<br />
<br />
An extended version is available at&amp;nbsp;<a href=&quot;https://bodenmillergroup.github.io/IMCDataAnalysis/&quot;>https://bodenmillergroup.github.io/IMCDataAnalysis/</a>.</p>]]></description>
      <pubDate>Mon, 09 Oct 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/An-end-to-end-workflow-for-multiplexed-image-processing-and-analysis..html</guid>
      <dc:date>2023-10-09T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group develops diffusion-based hierarchical multi-label object detection to analyze panoramic dental X-Rays</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Diffusion-Based-Hierarchical-Multi-label-Object-Detection-to-Analyze-Panoramic-Dental-X-Rays.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:75dbbc7c-cf03-4ef2-9989-473107fe8f6e/Screenshot%202023-11-20%20at%2012.33.47.png" width="90" height="60" />
      <description><![CDATA[<p>See Hamamci et al., <a href=&quot;https://link.springer.com/chapter/10.1007/978-3-031-43987-2_38&quot;>MICCAI 2023</a><br />
<br />
Numerous Machine Learning models for the interpretation of panoramic dental X-rays have been developed, yet none of them offers an end-to-end solution that identifies problematic teeth with dental enumeration and associated diagnoses at the same time. In this work, the Menze group structure three distinct types of annotated data hierarchically following the FDI system. To learn from all three hierarchies jointly, a novel diffusion-based hierarchical multi-label object detection framework is introduced by adapting a diffusion-based method that formulates object detection as a denoising diffusion process from noisy boxes to object boxes. Experimental results show that this novel method significantly outperforms state-of-the-art object detection methods.<br />
<br />
The code and the datasets are available at&amp;nbsp;<a href=&quot;https://github.com/ibrahimethemhamamci/HierarchicalDet&quot;>https://github.com/ibrahimethemhamamci/HierarchicalDet</a>.</p>]]></description>
      <pubDate>Sat, 30 Sep 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Diffusion-Based-Hierarchical-Multi-label-Object-Detection-to-Analyze-Panoramic-Dental-X-Rays.html</guid>
      <dc:date>2023-09-30T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group develops a self-pruning graph neural network for predicting inflammatory disease activity in Multiple Sclerosis from Brain MR Images</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Self-pruning-Graph-Neural-Network-for-Predicting-Inflammatory-Disease-Activity-in-Multiple-Sclerosis-from-Brain-MR-Images.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:75dbbc7c-cf03-4ef2-9989-473107fe8f6e/Screenshot%202023-11-20%20at%2012.33.47.png" width="90" height="60" />
      <description><![CDATA[<p>See Prabhakar et al., <a href=&quot;https://link.springer.com/chapter/10.1007/978-3-031-43993-3_22&quot;>MICCAI 2023</a><br />
<br />
Multiple Sclerosis (MS) is a severe neurological disease characterized by inflammatory lesions in the central nervous system. Predicting inflammatory disease activity is crucial for disease assessment and treatment. In this work, the Menze group presents the first attempt to utilize graph neural networks (GNN) to aggregate MS biomarkers for a novel global representation. A two-stage MS inflammatory disease activity prediction approach is proposed that detects lesions using &amp;nbsp;a 3D segmentation network and extracts their image features using a self-supervised algorithm. The detected lesions are used to build a patient graph, where the lesions act as nodes that are connected based on spatial proximity and the inflammatory disease activity prediction is formulated as a graph classification task. A self-pruning strategy auto-selects the most critical lesions for prediction. The proposed method outperforms the existing baseline by a large margin and offers&amp;nbsp;inherent explainability by assigning an importance score to each lesion for the overall prediction.<br />
<br />
Code is available at&amp;nbsp;<a href=&quot;https://github.com/chinmay5/ms_ida.git&quot;>https://github.com/chinmay5/ms_ida.git</a>.</p>]]></description>
      <pubDate>Sat, 30 Sep 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Self-pruning-Graph-Neural-Network-for-Predicting-Inflammatory-Disease-Activity-in-Multiple-Sclerosis-from-Brain-MR-Images.html</guid>
      <dc:date>2023-09-30T22:00:00Z</dc:date>
    </item>
    <item>
      <title>DQBM and the Institute for Implementation Science in Healthcare (IfIS) launch BME337: &quot;Introduction to Digital Health&quot;</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Introduction-to-Digital-Health.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:925090db-76ee-420e-b62a-a006f4d7793e/Screenshot%202023-09-15%20at%2015.25.09.png" width="90" height="60" />
      <description><![CDATA[<p>DQBM and the Institute for Implementation Science in Healthcare (IfIS) launch BME337: &quot;Introduction to Digital Health&quot; this Autumn semester. This course is open to MNF and Mef students alike.&amp;nbsp;<br />
&amp;nbsp;</p>

<p><a href=&quot;https://studentservices.uzh.ch/uzh/anonym/vvz/?sap-language=DE&amp;sap-ui-language=DE#/details/2023/003/SM/51206045&quot;>Link to BME337: Introduction to Digital Health in the course catalogue</a></p>

<p><br />
This course will provide an overview of tools, methods and applications driving digital health innovations. ln the course, students will gain first insights into the topic by UZH digital health experts presenting their latest research in clinical data science, imaging, mobile health, digital therapeutics, augmented reality and related domains. The course is the first one of five modules on &amp;#39;Digital Heath&amp;#39;, which aims at providing students with the fundamental knowledge about using data and computation in clinical research and digital health interventions. To prepare the students for the following modules, this introductory course will provide the necessary understanding of the key concepts in digital health at the intersection of (bio- and behavioural) medicine, data science, bioinformatics, and information systems.</p>

<p>Topics that will be introduced in this course include:</p>

<p>- General overview on how data, digital tools and Al are used in healthcare;</p>

<p>- Clinical data science and translational informatics;</p>

<p>- Biomedical lmage Analysis and Machine Learning;</p>

<p>- Digital Tools for Medical Knowledge and Decision Support;</p>

<p>- Mobile health data streams for real world evidence generation and public health;</p>

<p>- Digital therapeutics and health interventions for prevention, management, and treatment of diseases.</p>]]></description>
      <pubDate>Thu, 14 Sep 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Introduction-to-Digital-Health.html</guid>
      <dc:date>2023-09-14T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group develops DNA-barcoded signal amplification for imaging mass cytometry</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/DNA-barcoded-signal-amplification-for-imaging-mass-cytometry.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:d7f03e3d-7a5f-4096-b1c8-af94f1b17aa3/Screenshot%202023-09-06%20at%2011.13.10.png" width="90" height="60" />
      <description><![CDATA[<p><strong>DNA-barcoded signal amplification for imaging mass cytometry enables sensitive and highly multiplexed tissue imaging</strong></p>

<p>See Hosogane et al., <a href=&quot;https://doi.org/10.1038/s41592-023-01976-y&quot;>Nature Methods</a></p>

<p>In this work, the Bodenmiller group extends Imaging mass cytometry (IMC) to low-abundance markers through incorporation of the DNA-based signal amplification by exchange reaction, immuno-SABER. Using this novel method, the tumor immune microenvironment in human melanoma was analyzed by simultaneous imaging of 18 markers with immuno-SABER and 20 markers without amplification. SABER-IMC enabled the identification of immune cell phenotypic markers that are not detectable with IMC alone.</p>]]></description>
      <pubDate>Wed, 30 Aug 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/DNA-barcoded-signal-amplification-for-imaging-mass-cytometry.html</guid>
      <dc:date>2023-08-30T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group develops multielement Z-tag imaging by X-ray fluorescence microscopy</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Multielement-Z-tag-imaging-by-X-ray-fluorescence-microscopy-for-next-generation-multiplex-imaging.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:0e8e150f-4bb4-4a21-b3c2-6ad7488d7df6/Screenshot%202023-09-06%20at%2011.47.25.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Multielement Z-tag imaging by X-ray fluorescence microscopy for next-generation multiplex imaging</strong></p>

<p>See Strotton et al., <a href=&quot;https://doi.org/10.1038/s41592-023-01977-x&quot;>Nature Methods</a></p>

<p>Whole-organism to atomic-level imaging is possible with tissue-penetrant, picometer-wavelength X-rays. To enable highly multiplexed X-ray imaging, the Bodenmiller group developed multielement Z-tag X-ray fluorescence (MEZ-XRF) that can operate at kHz speeds when combined with signal amplification by exchange reaction (SABER)-amplified Z-tag reagents. Parallel imaging of 20 Z-tag or SABER Z-tag reagents at subcellular resolution was demonstrated in cell lines and multiple human tissues. The unique multiscale, nondestructive nature of MEZ-XRF, combined with SABER Z-tags for high sensitivity or enhanced speed, enables highly multiplexed bioimaging across biological scales.</p>]]></description>
      <pubDate>Wed, 30 Aug 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Multielement-Z-tag-imaging-by-X-ray-fluorescence-microscopy-for-next-generation-multiplex-imaging.html</guid>
      <dc:date>2023-08-30T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Kümmerli group explores bacterial strain-specific resistance evolution</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Rapid-and-strain-specific-resistance-evolution-of-Staphylococcus-aureus-against-inhibitory-molecules-secreted-by-Pseudomonas-aeruginosa.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:edfdad50-da44-4be5-8289-ae3fdc4db8ae/mBio%20default%20cover.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Rapid and strain-specific resistance evolution of&amp;nbsp;<em>Staphylococcus aureus</em>&amp;nbsp;against inhibitory molecules secreted by&amp;nbsp;<em>Pseudomonas aeruginosa</em></strong><br />
<br />
See Niggli et al., <a href=&quot;https://doi.org/10.1128/mbio.03153-22&quot;>mBio</a><br />
Polymicrobial infections are widespread and pathogenoc interaction potentially trigger evolutionary dynamics with pathogens adapting to each other. In this work, the K&amp;uuml;mmerli group explored the potential of <em>Staphylococcus aureus</em> to adapt to its competitor <em>Pseudomonas aeruginosa</em>. Experimental evolution experiments with three different <em>S. aureus</em> strains showed that <em>S. aureus</em> rapidly becomes resistant to inhibitory compounds secreted by <em>P. aeruginosa</em>. Three main factors contribute to strain-specific resistance evolution: (i) overproduction of a molecule that protects against oxidative stress; (ii) the formation of small colony variants that also protect against oxidative stress; and (iii) changes in membrane transporters that may reduce toxin uptake. Taken together, this work shows that species interactions can change over time, potentially favoring species coexistence, which in turn could influence disease progression and treatment options.</p>]]></description>
      <pubDate>Tue, 29 Aug 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Rapid-and-strain-specific-resistance-evolution-of-Staphylococcus-aureus-against-inhibitory-molecules-secreted-by-Pseudomonas-aeruginosa.html</guid>
      <dc:date>2023-08-29T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group develops a method to generate accurate synthetic CT images from MRI data</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Region-of-interest-focused-MRI-to-synthetic-CT-translation-using-regression-and-segmentation-multi-task-network..html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:1ca6e160-ff1a-493b-8ce6-67e3dabadcca/journal_cover.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Region of interest focused MRI to synthetic CT translation using regression and segmentation multi-task network</strong><br />
See Kaushik et al., <a href=&quot;https://doi.org/10.1088/1361-6560/acefa3&quot;>Phys Med Biol</a></p>

<p>In clinical workflow, replacing CT with MR image enhances workflow efficiency and reduces patient radiation. To eliminate CT from the workflow, &amp;nbsp;the information provided by CT needs to be generated via an MR image. In this work, the Menze group proposes a machine learning method to generate accurate synthetic CT (sCT) from MRI with a quantitative accuracy suitable for RT dose planning application, setting the stage for a broader clinical evaluation of sCT based RT planning on different anatomical regions.&amp;nbsp;</p>]]></description>
      <pubDate>Thu, 10 Aug 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Region-of-interest-focused-MRI-to-synthetic-CT-translation-using-regression-and-segmentation-multi-task-network..html</guid>
      <dc:date>2023-08-10T22:00:00Z</dc:date>
    </item>
    <item>
      <title>Michael Krauthammer takes over the DQBM Directorship from Bernd Bodenmiller per 01.08.2023</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Michael-Krauthammer-takes-over-DQBM-Directorship.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:9c58e8de-04e0-4fa2-b61d-e62e089921d5/F1dqsyhWAAI-Ob7.jpeg" width="90" height="60" />
      <description><![CDATA[<p>After 4,5 years, DQBM&amp;#39;s Founding Director Prof. Dr. Bernd Bodenmiller&amp;nbsp;has concluded his term as Head of Department, passing the gavel to Prof. Dr. Dr. Michael Krauthammer.<br />
<br />
We thank Bernd for his service and congratulate Michael on his new role!</p>]]></description>
      <pubDate>Mon, 31 Jul 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Michael-Krauthammer-takes-over-DQBM-Directorship.html</guid>
      <dc:date>2023-07-31T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Kümmerli group shows that negative interactions and virulence differences drive polymicrobial infection dynamics</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Negative-interactions-and-virulence-differences-drive-the-dynamics-in-multispecies-bacterial-infections.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:57b3c815-e4ce-49d1-a7b6-f66376e2334a/Screenshot%202023-08-02%20at%2013.05.23.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Negative interactions and virulence differences drive the dynamics in multispecies bacterial infections</strong><br />
See Schmitz et al., <a href=&quot;https://doi.org/10.1098/rspb.2023.1119&quot;>Proc Biol Sci.&amp;nbsp;</a><br />
<br />
Bacterial infections are often polymicrobial, leading to intricate pathogen-pathogen and pathogen-host interactions. Here, the K&amp;uuml;mmerli group co-infected larvae of&amp;nbsp;<em>Galleria mellonella&amp;nbsp;</em>with one to four opportunistic human pathogens to show that host mortality is always determined by the most virulent bacterial species, regardless of the number of species and pathogen combinations injected. This work reveals positive associations between a pathogen&amp;#39;s growth inside the host, its competitiveness towards other pathogens and its virulence, supporting the experimentally validated prediction that treatments against polymicrobial infections should first target the most virulent species to reduce host morbidity.</p>]]></description>
      <pubDate>Tue, 25 Jul 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Negative-interactions-and-virulence-differences-drive-the-dynamics-in-multispecies-bacterial-infections.html</guid>
      <dc:date>2023-07-25T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group publishes a cancer-associated fibroblast classification scheme</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Cancer-associated-fibroblast-classification-in-single-cell-and-spatial-proteomics-data.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:ae213ca7-8543-4d90-8083-a47631680d77/Screenshot%202023-08-02%20at%2013.24.52.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Cancer-associated fibroblast classification in single-cell and spatial proteomics data</strong><br />
See Cords et al., <a href=&quot;https://doi.org/10.1038/s41467-023-39762-1&quot;>Nature Communications</a></p>

<p>In this work, the Bodenmiller group defined cancer-associated fibroblast (CAF) phenotypes by analysing a single-cell RNA sequencing (scRNA-seq) dataset of over 16,000 stromal cells from tumours of 14 breast cancer patients, based on which nine CAF phenotypes and one class of pericytes were defined and functionally annotated. Next, the classification system was validated in four additional cancer types and highly multiplexed imaging mass cytometry was used on matched breast cancer samples to confirm the defined CAF phenotypes at the protein level and to analyse their spatial distribution within tumours. This general CAF classification scheme will allow comparison of CAF phenotypes across studies, facilitate analysis of their functional roles, and potentially guide development of new treatment strategies in the future.</p>]]></description>
      <pubDate>Mon, 17 Jul 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Cancer-associated-fibroblast-classification-in-single-cell-and-spatial-proteomics-data.html</guid>
      <dc:date>2023-07-17T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Polymenidou group shows that loss of TDP-43 oligomerization or RNA binding elicits distinct protein aggregation patterns</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Loss-of-TDP-43-oligomerization-or-RNA-binding-elicits-distinct-aggregation-patterns.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:bf49d4b6-481d-4e51-a3ba-e132243aa3a1/embj2022111719-abs-0001-m.jpg" width="90" height="60" />
      <description><![CDATA[<p><br />
<em><strong>Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns</strong></em><br />
See P&amp;eacute;rez-Berlanga et al., <a href=&quot;https://doi.org/10.15252/embj.2022111719&quot;>The EMBO Journal</a><br />
<br />
In disease, the RNA-binding protein TAR DNA-binding protein 43 (TDP-43) is known to form cytoplasmic or intranuclear inclusions, but how TDP-43 transitions from physiological to pathological states remains poorly understood. In this work, the Polymenidou group unravels the origins of heterogeneous pathological species reminiscent of those occurring in TDP-43 proteinopathy patients. By using human neurons and cell lines with near-physiological expression levels, oligomerization and RNA binding are shown to govern TDP-43 stability, splicing functionality, LLPS, and subcellular localization. Monomeric TDP-43 is found to form inclusions in the cytoplasm, whereas its RNA binding-deficient counterpart aggregates in the nucleus. These differentially localized aggregates emerge via distinct pathways: LLPS-driven aggregation in the nucleus and aggresome-dependent inclusion formation in the cytoplasm.</p>]]></description>
      <pubDate>Tue, 11 Jul 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Loss-of-TDP-43-oligomerization-or-RNA-binding-elicits-distinct-aggregation-patterns.html</guid>
      <dc:date>2023-07-11T22:00:00Z</dc:date>
    </item>
    <item>
      <title>Read Michael Krauthammer&#039;s conversation with Schweizerische Ärztezeitung on AI in medicine (in German)</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Michael-Krauthammer-Schweizerische-%C3%84rztezeitung.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:5806ddc1-be29-431c-bca0-e76af619a33e/de-small.svg" width="90" height="60" />
      <description><![CDATA[<p>Wie wird die K&amp;uuml;nstliche Intelligenz (KI) die Medizin ver&amp;auml;ndern? Ein Gespr&amp;auml;ch mit Medizininformatik-Professor Michael Krauthammer &amp;uuml;ber KI, die Medizinpr&amp;uuml;fungen besteht und k&amp;uuml;nftig vielleicht eigene Definitionen von Gesundheit und Krankheit entwickelt.<br />
<br />
<a href=&quot;https://doi.org/10.4414/saez.2023.21842&quot;>https://doi.org/10.4414/saez.2023.21842</a></p>

<p>&amp;nbsp;</p>

<p>&amp;nbsp;</p>

<p>Read more about the new BioMedical Informatics Platform in UZH News:&amp;nbsp;<a href=&quot;https://www.news.uzh.ch/en/articles/news/2023/loop-platform.html&quot;>&quot;Unlocking the Data Treasure Chest&quot;</a></p>]]></description>
      <pubDate>Tue, 30 May 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Michael-Krauthammer-Schweizerische-%C3%84rztezeitung.html</guid>
      <dc:date>2023-05-30T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group identifies prognostic single-cell populations in breast cancer lymph node metastases</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Multiplex-imaging-of-breast-cancer-lymph-node-metastases-identifies-prognostic-single-cell-populations-independent-of-clinical-classifiers.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:f9e7c7ed-7dcf-4e70-804d-382f6744bed1/Screenshot%202023-03-15%20at%2009.05.08.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers</strong></p>

<p>In this work, the Bodenmiller group uses multiplex imaging mass cytometry to analyze breast cancer patients&amp;#39; single tumor cell phenotypes, both in primary tumors and in matched lymph node metastases. They report high phenotypic variability between these tissue sites and identify high- and low-risk disseminated cell phenotypes and prognostic markers.<br />
See Fischer et al., <a href=&quot;https://doi.org/10.1016/j.xcrm.2023.100977&quot;>Cell Reports Medicine</a></p>]]></description>
      <pubDate>Mon, 13 Mar 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Multiplex-imaging-of-breast-cancer-lymph-node-metastases-identifies-prognostic-single-cell-populations-independent-of-clinical-classifiers.html</guid>
      <dc:date>2023-03-13T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller lab and collaborators receive 2 mCHF for the CCCZ Lighthouse Project &quot;IMMUNO-CAR ZURICH&quot;</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/The-Bodenmiller-lab-CCCZ-Lighthouse-Project-IMMUNO-CAR-ZURICH.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:840a71f5-7be5-4bc6-8336-c201e48e3ea7/Screenshot%202023-06-05%20at%2008.19.50.png" width="90" height="60" />
      <description><![CDATA[<p>IMMUNO-CAR ZURICH (ZURICAR) aims to develop innovative platforms within the &amp;nbsp;Comprehensive Cancer Center Zurich&amp;nbsp;(CCCZ) for the effective, flexible, safe and cost-efficient production of Chimeric Antigen Receptor (CAR) immune cells, which will be manufactured at Wyss Zurich and subsequently used in Phase I clinical trials in patients with an urgent need for effective therapies. This highly translational, patient-centered approach is accompanied by state-of-the-art immune monitoring during therapy and research to improve the efficacy of CAR cells.<br />
<br />
Read more about the IMMUNO-CAR ZURICH project&amp;nbsp;on the <a href=&quot;https://www.usz.ch/en/clinic/comprehensive-cancer-center-zuerich/research/translational-interdisciplinary-cancer-research-programs/zuricar/&quot;>CCCZ website</a></p>]]></description>
      <pubDate>Tue, 02 May 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/The-Bodenmiller-lab-CCCZ-Lighthouse-Project-IMMUNO-CAR-ZURICH.html</guid>
      <dc:date>2023-05-02T22:00:00Z</dc:date>
    </item>
    <item>
      <title>Magdalini Polymenidou becomes Novartis Institutes for BioMedical Research (NIBR) Global Scholar</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/NIBR-Globar-Scholar.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:17d88520-d42d-4529-95bf-6472f59e1a95/Polymenidou.jpg" width="90" height="60" />
      <description><![CDATA[<p>Congratulations to Prof. Dr. Magdalini Polymenidou, who was selected to become&amp;nbsp;Novartis Institutes for BioMedical Research (NIBR) Global Scholar. The&amp;nbsp;NIBR&amp;nbsp;Global Scholars Program (NGSP) is a competitive program that seeks to advance science by supporting projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Magdalini Polymenidou has been selected for the NGSP 2022 and will receive up to 1 mil USD funding over three years along with scientific expertise from NIBR collaborators.<br />
<br />
Please read the full <a href=&quot;https://www.innovation.uzh.ch/en/news/news/06.02.2023-Polymenidou-Global-Scholar-NIBR.html&quot;>UZH News</a> article <a href=&quot;https://www.innovation.uzh.ch/en/news/news/06.02.2023-Polymenidou-Global-Scholar-NIBR.html&quot;>here</a>.<br />
<br />
<em>Photo: Magdalini Polymenidou (by Pascal Halder www.naturphotos.ch)</em><br />
&amp;nbsp;</p>]]></description>
      <pubDate>Wed, 26 Apr 2023 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/NIBR-Globar-Scholar.html</guid>
      <dc:date>2023-04-26T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group publishes a deep learning approach to predict collateral flow in stroke patients</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/A-deep-learning-approach-to-predict-collateral-flow-in-stroke-patients.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:584eaaac-ba66-46fe-9570-d1ba461d6c8a/Screenshot%202023-03-13%20at%2008.01.35.png" width="90" height="60" />
      <description><![CDATA[<p><strong>A deep learning approach to predict collateral flow in stroke patients using radiomic features from perfusion images</strong></p>

<p>In this work, the Menze group presents a multi-stage deep learning approach to predict collateral flow grading in stroke patients. Based on radiomic features extracted from MR perfusion data, a region of interest (RoI) detection task is formulated as a reinforcement learning problem and used to train a deep learning network to automatically detect the occluded region within the 3D MR perfusion volumes.&amp;nbsp;Next, radiomic features are extracted from the obtained RoI through local image descriptors and denoising auto-encoders. Finally, a convolutional neural network and other machine learning classifiers are applied to the extracted radiomic features to automatically predict the collateral flow grading of the given patient volume as one of three severity classes. This automated deep learning approach is faster than visual inspection, eliminates grading bias and&amp;nbsp;demonstrates a performance comparable to expert grading.</p>

<p>See Tetteh et al., <a href=&quot;https://www.frontiersin.org/articles/10.3389/fneur.2023.1039693/full&quot;>Front Neurol</a></p>]]></description>
      <pubDate>Sun, 12 Mar 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/A-deep-learning-approach-to-predict-collateral-flow-in-stroke-patients.html</guid>
      <dc:date>2023-03-12T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group publishes Focused Decoder: a novel Detection Transformer for 3D anatomical structure detection</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Focused-Decoding-Enables-3D-Anatomical-Detection-by-Transformers.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:f8bd2241-2551-473e-8b72-3199b2b05ce1/Screenshot%202023-03-06%20at%2009.21.56.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Focused Decoding Enables 3D Anatomical Detection by Transformers</strong></p>

<p>In this work, the Menze group proposes a novel Detection Transformer for 3D anatomical structure detection, dubbed Focused Decoder. Focused Decoder precisely focuses on relevant anatomical structures, using anatomical region atlas information to deploy query anchors, while at the same time restricting the cross-attention&amp;rsquo;s field of view to regions of interest. Evaluated on two publicly available CT datasets, Focused Decoder is shown to provide both strong detection results, as well as highly intuitive explainability via attention weights.</p>

<p>See Wittmann et al.,<a href=&quot;https://www.melba-journal.org/pdf/2023:003.pdf&quot;>Journal of Machine Learning for Biomedical Imaging</a><br />
Code is available at&amp;nbsp;<a href=&quot;https://github.com/bwittmann/transoar&quot;>https://github.com/bwittmann/transoar</a></p>]]></description>
      <pubDate>Sun, 26 Feb 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Focused-Decoding-Enables-3D-Anatomical-Detection-by-Transformers.html</guid>
      <dc:date>2023-02-26T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Michael Krauthammer co-manages the establishment of the LOOP Zurich&#039;s new BioMedical Informatics Platform</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Unlocking-the-Data-Treasure-Chest.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:a6b45f5b-1f17-43a4-b8ed-db5fff0886f9/Screenshot%202023-02-16%20at%2014.11.29.png" width="90" height="60" />
      <description><![CDATA[<p>The LOOP Zurich is establishing a central health data platform to enable FAIR data exchange between UZH, ETHZ and the four university hospitals in Zurich.&amp;nbsp;Michael Krauthammer is the co-project manager of this&amp;nbsp;new BioMedical Informatics Platform (BMIP), together with Prof. Gunnar R&amp;auml;tsch from ETHZ.</p>

<p>Read more about the new BioMedical Informatics Platform in UZH News:&amp;nbsp;<a href=&quot;https://www.news.uzh.ch/en/articles/news/2023/loop-platform.html&quot;>&quot;Unlocking the Data Treasure Chest&quot;</a></p>]]></description>
      <pubDate>Wed, 15 Feb 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Unlocking-the-Data-Treasure-Chest.html</guid>
      <dc:date>2023-02-15T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Krauthammer lab and collaborators publish PRIDICT: An attention-based bidirectional recurrent neural network to predict prime editing efficiency and product purity</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Predicting-prime-editing-efficiency-and-product-purity-by-deep-learning.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:270d9869-b89a-4997-b5ca-b54a6a692161/Screenshot%202023-01-17%20at%2009.55.55.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Predicting prime editing efficiency and product purity by deep learning</strong></p>

<p>In this work, the Krauthammer lab and collaborators conducted a high-throughput screen to analyze prime editing outcomes of >90K pegRNAs on a set of >13K human pathogenic mutations. This dataset yielded sequence context features that influence prime editing and was subsequently used to train PRIDICT; an attention-based bidirectional recurrent neural network. PRIDICT reliably predicts editing rates for all small-sized genetic changes. Validation of PRIDICT, both on endogenous editing sites as well as on an external dataset, showed that pegRNAs with high versus low PRIDICT scores showed increased prime editing efficiencies in different cell types <em>in vitro</em> (12-fold) and in hepatocytes <em>in vivo</em> (tenfold), highlighting the value of PRIDICT for basic and translational research applications. PRIDICT is freely accessible at <a href=&quot;http://www.pridict.it/&quot;>www.pridict.it</a>.</p>

<p>See Mathis, Allam et al., <a href=&quot;https://doi.org/10.1038/s41587-022-01613-7&quot;>Nature Biotechnology</a></p>

<p>This work is featured on UZH News:&amp;nbsp;<a href=&quot;https://www.news.uzh.ch/en/articles/media/2023/Genome-Editing.html&quot;>Artificial Intelligence Improves Efficiency of Genome Editing</a></p>]]></description>
      <pubDate>Sun, 15 Jan 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Predicting-prime-editing-efficiency-and-product-purity-by-deep-learning.html</guid>
      <dc:date>2023-01-15T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group publishes a single-cell map of T cell exhaustion-associated immune environments in breast cancer</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/A-comprehensive-single-cell-map-of-T-cell-exhaustion-associated-immune-environments-in-human-breast-cancer.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:52092e1e-d2c0-4426-90c6-f1cd19ce59c4/Tietscher%202023.png" width="90" height="60" />
      <description><![CDATA[<p><strong>A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer</strong></p>

<p>Immune checkpoint therapy aims at preventing or reversing exhausted T cell states, but in breast cancer,&amp;nbsp;T cell exhaustion is poorly understood. In this work, the Bodenmiller group used single-cell transcriptomics combined with imaging mass cytometry to systematically study immune environments of human luminal breast tumors with and without exhausted T cells. The data show that expression of PD-1 and CXCL13 on T cells, and MHC-I &amp;ndash; but not PD-L1 &amp;ndash; on tumor cells on tumor cells are powerful differentiators between these environments.<br />
See Tietscher et al., <a href=&quot;https://doi.org/10.1038/s41467-022-35238-w&quot;>Nat Communications</a></p>]]></description>
      <pubDate>Thu, 05 Jan 2023 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/A-comprehensive-single-cell-map-of-T-cell-exhaustion-associated-immune-environments-in-human-breast-cancer.html</guid>
      <dc:date>2023-01-05T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Polymenidou group and collaborators systematically evaluate human-derived anti-poly-GA antibodies in C9orf72 disease models</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Comprehensive-evaluation-of-human-derived-anti-poly-GA-antibodies-in-cellular-and-animal-models-of-C9orf72-disease.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:76287f88-af47-4997-a04b-08b641531fb1/pnas.2123487119fig01.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of&amp;nbsp;<em>C9orf72</em>&amp;nbsp;disease</strong></p>

<p>Hexanucleotide G<sub>4</sub>C<sub>2</sub>&amp;nbsp;repeat expansions in the&amp;nbsp;<em>C9orf72</em>&amp;nbsp;gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Dipeptide repeat proteins (DPRs) generated by translation of repeat-containing RNAs are key targets for therapeutic intervention. In this work, the Polymenidou group and collaborators generated human antibodies that bind DPRs with high affinity and specificity, systematically characterized these against multiple DPR species and tested the biological effects of antibodies targeting poly-GA in different cellular and mouse models.&amp;nbsp;</p>

<p>See Jambeau et al, <a href=&quot;https://doi.org/10.1073/pnas.2123487119&quot;>PNAS</a></p>]]></description>
      <pubDate>Wed, 30 Nov 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Comprehensive-evaluation-of-human-derived-anti-poly-GA-antibodies-in-cellular-and-animal-models-of-C9orf72-disease.html</guid>
      <dc:date>2022-11-30T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group and collaborators publish the liver tumor segmentation benchmark</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/The-Liver-Tumor-Segmentation-Benchmark-%28LiTS%29.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:e556bb99-5448-427e-9c15-74df55f26726/Graphical%20abstract.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>The Liver Tumor Segmentation Benchmark (LiTS)</strong></p>

<p>In this work, the Menze group and collaborators report the set-up and results of the Liver Tumor Segmentation Benchmark (LiTS), which was organized in conjunction with the IEEE International Symposium on Biomedical Imaging (ISBI) 2017 and the International Conferences on Medical Image Computing and Computer-Assisted Intervention (MICCAI) 2017 and 2018. There was not a single algorithm that performed best for both liver and liver tumors in these three events. The best liver segmentation algorithm achieved a Dice score of 0.963, whereas the best algorithms for tumor segmentation achieved Dices scores of 0.674 (ISBI 2017), 0.702 (MICCAI 2017), and 0.739 (MICCAI 2018). Retrospectively, additional analysis on liver tumor detection revealed that not all top-performing segmentation algorithms worked well for tumor detection: The best liver tumor detection method achieved a lesion-wise recall of 0.458 (ISBI 2017), 0.515 (MICCAI 2017), and 0.554 (MICCAI 2018), indicating the need for further research. Nonetheless, LiTS remains an active benchmark and resource for research. See Bilic et al., <a href=&quot;https://doi.org/10.1016/j.media.2022.102680&quot;>Med Image Anal.</a><br />
Both data and online evaluation are accessible via&amp;nbsp;<a href=&quot;https://competitions.codalab.org/competitions/17094&quot; rel=&quot;noreferrer noopener&quot; target=&quot;_blank&quot;>https://competitions.codalab.org/competitions/17094</a>.</p>]]></description>
      <pubDate>Sat, 31 Dec 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/The-Liver-Tumor-Segmentation-Benchmark-%28LiTS%29.html</guid>
      <dc:date>2022-12-31T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group develops a strategy that estimates tissue spatial segregation to optimise multiplexed imaging experimental design</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Optimizing-multiplexed-imaging-experimental-design-through-tissue-spatial-segregation-estimation0.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:370de699-cbcd-44aa-a1a5-6f8edbfbf393/Bost%20Fig%202%20small.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Optimizing multiplexed imaging experimental design through tissue spatial segregation estimation</strong></p>

<p>Multiplexed imaging methods allow simultaneous detection of dozens of proteins and hundreds of RNAs, but parameters for the design of optimal multiplex imaging studies are lacking. In this work, the Bodenmiller group developed a statistical framework that determines the number and area of fields of view necessary to accurately identify all cell phenotypes that are part of a tissue. This strategy was then used on imaging mass cytometry data to identify a measurement of tissue spatial segregation that enables optimal experimental design.&amp;nbsp;See Bost et al., <a href=&quot;https://doi.org/10.1038/s41592-022-01692-z&quot;>Nat Methods</a></p>]]></description>
      <pubDate>Thu, 29 Dec 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Optimizing-multiplexed-imaging-experimental-design-through-tissue-spatial-segregation-estimation0.html</guid>
      <dc:date>2022-12-29T23:00:00Z</dc:date>
    </item>
    <item>
      <title>DQBM&#039;s roundup of 2022</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Synopsis-2022.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:ab244be8-2998-4eaa-a336-d8ceb4529772/2022%20DQBM%20Retreat%20Group%20photo_small.jpg" width="90" height="60" />
      <description><![CDATA[<p>Founded in 2019, the DQBM&amp;#39;s mission is to foster research and education at the interface of biomedical research, biotechnology, and computational biomedicine, to develop the foundations of next-generation precision medicine. Ultimately, our goal is to advance precision medicine for the benefit of patients. To fulfil our mission, we rely on excellent science done by outstanding scientists. Here, we highlight the DQBM events and academic achievements in 2022.</p>]]></description>
      <pubDate>Wed, 21 Dec 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Synopsis-2022.html</guid>
      <dc:date>2022-12-21T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Polymenidou group&#039;s research is featured in EU GrantsAccess&#039; Science Stories</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/A-NEW-PERSPECTIVE-ON-NEURODEGENERATIVE-DISEASES.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:ff622ee7-c952-45cc-a31d-682cdf8158a6/polymenidou_titel_700.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>A new perspective on neurodegenerative diseases</strong></p>

<p>Read <a href=&quot;https://science-stories.ch/polymenidou/&quot;>EU GrantsAccess&amp;#39; Science Stories feature on the Polymenidou group</a>&amp;#39;s research.</p>]]></description>
      <pubDate>Thu, 15 Dec 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/A-NEW-PERSPECTIVE-ON-NEURODEGENERATIVE-DISEASES.html</guid>
      <dc:date>2022-12-15T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Kümmerli group shows that collective decision-making in P. aeruginosa involves transient segregation of quorum-sensing activities across cells</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/transient-segregation-of-quorum-sensing-activities-across-cells.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:3263cef6-310c-4e68-8fb8-a68877fc3b44/Graphical%20abstract.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Collective decision-making in&amp;nbsp;<em>Pseudomonas&amp;nbsp;</em><em>aeruginosa</em>&amp;nbsp;involves transient segregation of quorum-sensing activities across cells</strong></p>

<p>Bacterial groups can coordinate cooperative actions through a communication process called quorum sensing (QS). However, whether individual bacteria coordinate their QS actions at the single-cell level, or whether group QS phenotypes are the sum of their noisy members, is unknown. Here, the K&amp;uuml;mmerli group tracked the temporal commitments of individual <em>Pseudomonas aeruginosa</em> bacteria to the intertwined Las and Rhl-QS systems, from low to high population density. QS gene expression was shown to be noisy, with heterogeneity peaking during the build-up phase of QS. Discrete subgroups of cells formed that transiently segregated into two gene expression states: low Las-receptor expressers and high Las-receptor expressers. Over time, gene expression activities converged with all cells fully committing to QS. Using general mathematical models, the K&amp;uuml;mmerli group was able to show that molecular resource limitations during the initiation phase of regulatory cascades can mechanistically trigger gene expression segregation across cells. This mechanism can operate as a built-in brake enabling a temporary bet-hedging strategy in unpredictable environments. Together, this work reveals that studying the behavior of bacterial individuals is key to understanding emergent collective actions at the group level.</p>

<p>See Jayakumar et al., <a href=&quot;https://doi.org/10.1016/j.cub.2022.10.052&quot;>Current Biology</a></p>]]></description>
      <pubDate>Mon, 21 Nov 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/transient-segregation-of-quorum-sensing-activities-across-cells.html</guid>
      <dc:date>2022-11-21T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Michael Krauthammer and collaborators publish a perspective paper on the use and ethics of Digital Twins in medicine</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/The-Use-and-Ethics-of-Digital-Twins-in-Medicine.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:f27985a2-5aaa-426d-81f7-c7840a794cfa/figure%202.png" width="90" height="60" />
      <description><![CDATA[<p><strong>The Use and Ethics of Digital Twins in Medicine</strong></p>

<p>This work introduces both the concept and use cases of digital twins in medicine, frames the debate on their ethical, legal and societal implications&amp;nbsp;through the lens of related health digital technologies, machine learning and personalized medicine, and maps ethical challenges stemming from those. Finally, the authors lay out how digital twins may change and challenge the future practice of medicine.</p>

<p>See Iqbal, Krauthammer and Biller-Andorno,&amp;nbsp;<a href=&quot;https://doi.org/10.1017/jme.2022.97&quot;>The Journal of Law, Medicine &amp; Ethics</a></p>

<p>&amp;nbsp;</p>]]></description>
      <pubDate>Thu, 17 Nov 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/The-Use-and-Ethics-of-Digital-Twins-in-Medicine.html</guid>
      <dc:date>2022-11-17T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group publishes a new way of solving the inverse problem for brain tumor modeling</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Learn-Morph-Infer.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:1480419d-4f7d-48d6-a6fc-1d2637a0d2b0/Graphical%20abstract.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Learn-Morph-Infer: A new way of solving the inverse problem for brain tumor modeling</strong></p>

<p>Current treatment planning of patients diagnosed with a brain tumor could benefit from assessment of the spatial distribution of tumor cell concentration. Magnetic resonance imaging (MRI) can reveal areas of high cell density in gliomas, but areas of low cell concentration, which&amp;nbsp;can serve as a source for the secondary appearance of the tumor after treatment, are not detected.&amp;nbsp;To estimate tumor cell densities beyond the visible boundaries of the lesion, numerical simulations of tumor growth could complement imaging information by providing estimates of full spatial distributions of tumor cells. In this work, the Menze group introduces Learn-Morph-Infer:&amp;nbsp;a deep learning based methodology for inferring the patient-specific spatial distribution of brain tumors from T1Gd and FLAIR MRI medical scans. The method achieves real-time performance in the order of minutes on widely available hardware and the compute time is stable across tumor models of different complexity. As such, the proposed inverse solution approach allows for clinical translation of brain tumor personalization and could also be adopted to other scientific and engineering domains.</p>

<p>See Ezhov et al., <a href=&quot;https://doi.org/10.1016/j.media.2022.102672&quot;>Med Image Anal.</a><br />
&amp;nbsp;</p>]]></description>
      <pubDate>Fri, 04 Nov 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Learn-Morph-Infer.html</guid>
      <dc:date>2022-11-04T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Kümmerli group shows that loss-of-function and regulon modulation drives diversification in quorum sensing activity patterns in P. aeruginosa</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Evolution-of-Quorum-Sensing-in-Pseudomonas-aeruginosa-Can-Occur-via-Loss-of-Function-and-Regulon-Modulation.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:027a280c-a591-43bd-adf7-578618214806/msystems.00354-22-f001.gif" width="90" height="60" />
      <description><![CDATA[<p><strong>Evolution of quorum sensing in <em>Pseudomonas aeruginosa</em> can occur via loss of function and regulon modulation</strong></p>

<p><em>Pseudomonas aeruginosa</em> uses quorum sensing (QS) to coordinate expression of traits required for growth and virulence in the context of infections. Despite its importance for bacterial fitness, the QS regulon appears to be a common mutational target during long-term adaptation of <em>P. aeruginosa</em> in the host, natural environments, and experimental evolutions. By examining mutation types in the three QS regulons of 61 experimentally evolved QS mutants, the K&amp;uuml;mmerli group found that mutations involving the master regulator, LasR, resulted in an almost complete breakdown of QS, whereas mutations in RhlR and PqsR resulted in changes in regulon structure and the QS-regulated trait profile. Beyond affecting the plasticity and diversity of evolved populations, these mutations might also impact bacterial fitness and virulence during infections.</p>

<p>See Jayakumar, Figueiredo &amp; K&amp;uuml;mmerli, <a href=&quot;https://journals.asm.org/doi/epub/10.1128/msystems.00354-22&quot;>mSystems</a></p>]]></description>
      <pubDate>Sun, 02 Oct 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Evolution-of-Quorum-Sensing-in-Pseudomonas-aeruginosa-Can-Occur-via-Loss-of-Function-and-Regulon-Modulation.html</guid>
      <dc:date>2022-10-02T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group improves deep learning based super-resolution of 4D-flow MRI data</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/SRflow-deep-learning-based-super-resolution-of-4D-flow-MRI-data.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:f789d639-08e7-445a-a43f-700b516bfc54/frai-05-928181-g0006.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>SRflow: Deep learning based super-resolution of 4D-flow MRI data</strong></p>

<p>The quantification of hemodynamics using 4D-flow magnetic resonance imaging (MRI) data requires an adequate spatio-temporal vector field resolution at a low noise level. Here, the Menze group provides a deep convolutional neural network (CNN) that learns the inter-scale relationship of the velocity vector map and leverages an efficient residual learning scheme to make it computationally feasible. A detailed comparative study between the proposed super-resolution and the conventional cubic B-spline based vector-field super-resolution shows that the new method not only improves the peak-velocity to noise ratio of the flow field by 10% and 30% for <em>in vivo</em> cardiovascular and cerebrovascular data, respectively, for 4 &amp;times; super-resolution, but also offers 10x faster inference over the state-of-the-art.</p>

<p>See Shit et al., <a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411720/&quot;>Front. Artif. Intell</a><br />
&amp;nbsp;</p>]]></description>
      <pubDate>Sun, 11 Sep 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/SRflow-deep-learning-based-super-resolution-of-4D-flow-MRI-data.html</guid>
      <dc:date>2022-09-11T22:00:00Z</dc:date>
    </item>
    <item>
      <title>Magdalini Polymenidou granted a Target ALS and Alzheimer’s Drug Discovery Foundation Award for Biomarker Research</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Magdalini-Polymenidou-awarded-Target-ALS-and-Alzheimer%E2%80%99s-Drug-Discovery-Foundation-Award-for-Biomarker-Research.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:0b9918fb-cdb1-4b46-86b7-882224c72329/Screenshot%202022-09-14%20at%2013.36.15.png" width="90" height="60" />
      <description><![CDATA[<p>We congratulate <strong>Prof. Dr. Magdalini Polymenidou </strong>and her lab&amp;nbsp;<span style=&quot;font-style:normal; text-align:start&quot;><span style=&quot;font-weight:400&quot;><span style=&quot;white-space:normal&quot;><span style=&quot;text-decoration:none&quot;><span style=&quot;color:#3f4350&quot;>for receiving the <a href=&quot;https://www.targetals.org/2022/08/30/target-als-and-alzheimers-drug-discovery-foundation-announce-award-recipients-for-biomarker-research/?utm_source=Email&amp;utm_medium=newsletter&amp;utm_campaign=083022&amp;bbeml=tp-hIaucjw80kqW9_-KXJ64gQ.jIIKPHJKhb0qsafYOiOn_vw.rhGTOrh7ihEWAOey_omxrFA.lFs67wht8-0epi_kRJ99jcQ&quot;>Target ALS and Alzheimer&amp;rsquo;s Drug Discovery Foundation Award for Biomarker Research</a>, for their collaborative project with the University of Verona and Trieste International School for Advanced Studies. </span></span></span></span></span><span style=&quot;font-style:normal; text-align:start&quot;><span style=&quot;font-weight:400&quot;><span style=&quot;white-space:normal&quot;><span style=&quot;text-decoration:none&quot;><span style=&quot;color:#3f4350&quot;>The consortium will work towards the development of a diagnostic test for TDP-43 proteinopathies using nasal swabs.</span></span></span></span></span></p>

<p>&amp;nbsp;</p>]]></description>
      <pubDate>Mon, 29 Aug 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Magdalini-Polymenidou-awarded-Target-ALS-and-Alzheimer%E2%80%99s-Drug-Discovery-Foundation-Award-for-Biomarker-Research.html</guid>
      <dc:date>2022-08-29T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Krauthammer lab is part of the newly funded DIZH innovation structure &quot;Zurich Applied Digital Health Center&quot;</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Michael-Krauthammer-Innosuisse-Flagship-Smart-Hospitals0.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:d06a3e2e-a0b4-4511-ba75-de93c26be87d/ZADHC_Grafik-2.png" width="90" height="60" />
      <description><![CDATA[<p>Michael Krauthammer is core team member of the newly funded DIZH innovation structure <a href=&quot;https://dizh.ch/en/2022/07/07/zurich-applied-digital-health-center-2/&quot;>Zurich Applied Digital Health Center</a>: a practice lab for patient-centered clinical innovation.</p>

<p>&amp;nbsp;</p>]]></description>
      <pubDate>Mon, 11 Jul 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Michael-Krauthammer-Innosuisse-Flagship-Smart-Hospitals0.html</guid>
      <dc:date>2022-07-11T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Kümmerli group shows coordination of siderophore gene expression in clonal P. aeruginosa cells</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Coordination-of-siderophore-gene-expression-among-clonal-cells-of-the-bacterium-Pseudomonas-aeruginosa.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:48a2a7e5-47b9-4c26-96b4-014261a9f88b/Screenshot%202022-06-08%20at%2009.38.20.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Coordination of siderophore gene expression among clonal cells of the bacterium <em>Pseudomonas aeruginosa</em></strong></p>

<p>An open question in microbiology is whether seemingly coordinated group-level responses, such as biofilm formation, actually mirror what individual cells do. To tackle this question, the K&amp;uuml;mmerli group used single-cell microscopy to simultaneously quantify the investment of individual P. aeruginosa cells into two public goods. Using gene expression as a proxy for investment, these bacterial cells initially show no coordination in siderophore investment, but rather high heterogeneity and bi-modality. However, with increasing cell density, gene expression becomes more homogenised across cells, with positive associations in siderophore gene expression across cells and with cell-to-cell variation correlating with cellular metabolic states.&amp;nbsp;This suggests that siderophore-mediated signalling aligns behavior of individual bacteria over time and spurs a coordinated three-phase siderophore investment cycle, covering the time spans from low to high population density, steered by the various interconnected regulatory mechanisms governing siderophore synthesis.</p>

<p>See Mridha &amp; K&amp;uuml;mmerli, <a href=&quot;https://www.nature.com/articles/s42003-022-03493-8&quot;>Commun. Biol.</a></p>]]></description>
      <pubDate>Sun, 05 Jun 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Coordination-of-siderophore-gene-expression-among-clonal-cells-of-the-bacterium-Pseudomonas-aeruginosa.html</guid>
      <dc:date>2022-06-05T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group&#039;s research is featured in EU GrantsAccess&#039; Science Stories</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/WITH-THE-THREE-DIMENSIONAL-CELL-ATLAS-TO-PRECISION-MEDICINE.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:e266f224-2793-4d00-95db-1a9dfd9c2084/Science%20Stories.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>With the Three-Dimensional Cell Atlas to Precision Medicine</strong></p>

<p>Read <a href=&quot;https://news.ethz.ch/html_mail.jsp?params=mpIpGpd6fnzx6KFibS9Kep1%2FxGKGW1i2xbu2bcDvW5CFmlWrqPUA5UQnILy9R10F4qinCfB7c0wTcus1XelQxwBXacw9E%2FcwG9RJLl%2B1LOE%3D&quot;>EU GrantsAccess&amp;#39; Science Stories feature on the Bodenmiller group</a>&amp;#39;s research.</p>]]></description>
      <pubDate>Wed, 18 May 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/WITH-THE-THREE-DIMENSIONAL-CELL-ATLAS-TO-PRECISION-MEDICINE.html</guid>
      <dc:date>2022-05-18T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Joller group publishes a review on the interplay between regulatory T cells and peripheral tissues</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Moving-to-the-Outskirts-Interplay-Between-Regulatory-T-Cells-and-Peripheral-Tissues.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:fc16b4d0-f890-4c8e-98e7-9ed47e01b444/fimmu-13-864628-g002.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Moving to the Outskirts: Interplay Between Regulatory T Cells and Peripheral Tissues</strong></p>

<p>Regulatory T cells (Tregs) curb excessive immune responses and dampen inflammation. Furthermore, in non-lymphoid tissues, Tregs promote tissue homeostasis, regeneration and repair. Profound understanding of the tissue-specific adaptations and functions of these Tregs might pave the way for therapeutic approaches targeting their regenerative role. In this review, the Joller group outlines their current understanding of how Tregs migrate into peripheral tissues and the factors required for their maintenance at these sites. Furthermore, tissue-specific adaptations of Tregs at barrier and immuno-privileged sites are discussed, as well as the mechanisms that regulate Tregs&amp;#39; function within these organs. Finally, this work outlines what is known about the interactions of Tregs with non-immune cells in the different peripheral tissues at steady state and upon challenge or tissue damage.</p>

<p>See Estrada Brull, Panetti &amp; Joller, <a href=&quot;https://doi.org/10.3389/fimmu.2022.864628&quot;>Frontiers in Immunology</a></p>]]></description>
      <pubDate>Thu, 28 Apr 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Moving-to-the-Outskirts-Interplay-Between-Regulatory-T-Cells-and-Peripheral-Tissues.html</guid>
      <dc:date>2022-04-28T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group develops a convolutional neural network for residual motion correction in fast whole-brain MRI</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Learning-residual-motion-correction-for-fast-and-robust-3D-multiparametric-MRI.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:513e6c27-2916-403f-a231-9306f7711bcd/Graphical%20abstract%20Pirkl.jpg" width="90" height="60" />
      <description><![CDATA[<p><strong>Learning residual motion correction for fast and robust 3D multiparametric MRI</strong></p>

<p>In routine clinical quantitative magnetic resonance imaging (MRI), motion artifacts affect parameter estimation and thus data quality. In this work, the Menze group presents a multiscale 3D convolutional neural network (CNN) that learns the nonlinear relationship between motion-influenced quantitative parameter maps and the residual error to their motion-free reference. A physically informed simulation is proposed for supervised model training, which generates independent paired data sets from a priori motion-free data. The proposed motion correction CNN outperforms the current state-of-the-art and reliably provides high, clinically relevant image quality for mild to pronounced patient motion.</p>

<p>See Pirkl et al., <a href=&quot;https://www.sciencedirect.com/science/article/pii/S1361841522000391?via%3Dihub&quot;>Med. Image Anal.&amp;nbsp;</a><br />
&amp;nbsp;</p>]]></description>
      <pubDate>Sun, 24 Apr 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Learning-residual-motion-correction-for-fast-and-robust-3D-multiparametric-MRI.html</guid>
      <dc:date>2022-04-24T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Kümmerli group shows that enforced specialization fosters mutual cheating, but not division of labour, in P. aeruginosa</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Enforced-specialization-fosters-mutual-cheating-and-not-division-of-labour-in-the-bacterium-Pseudomonas-aeruginosa.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:edd2f645-e36f-404c-b39f-cc171d542543/Mridha%202022.webp" width="90" height="60" />
      <description><![CDATA[<p><strong>Enforced specialization fosters mutual cheating and not division of labour in the bacterium <em>Pseudomonas aeruginosa</em></strong></p>

<p>An open question in microbiology is whether natural selection can favour division of labour where subpopulations or species specialise in the production of a single public good, whilst sharing the complementary goods at the group level. In this work, the K&amp;uuml;mmerli group explored the conditions under which specialisation can lead to division of labour. By growing engineered specialists of the bacterium <em>P. aeruginosa</em>, each of which which only produce one of two siderophores, at different mixing ratios under varying levels of iron limitation, they could show that enforcing specialisation with regard to siderophore production does not lead to beneficial division of labour in <em>P. aeruginosa</em>. Rather, this enforced specialisation leads to the stable co-existence of the two specialists through mutual cheating. Mridha and K&amp;uuml;mmerli propose that in generalists, natural selection might favour fine-tuned regulatory mechanisms over division of labour, because in fluctuating environments, this fine-tuning allows generalists to maintain the flexibility to adequately adjust public good investments.</p>

<p>See Mridha &amp; K&amp;uuml;mmerli, <a href=&quot;https://onlinelibrary.wiley.com/doi/10.1111/jeb.14001&quot;>J Evol Biol.</a></p>]]></description>
      <pubDate>Mon, 04 Apr 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Enforced-specialization-fosters-mutual-cheating-and-not-division-of-labour-in-the-bacterium-Pseudomonas-aeruginosa.html</guid>
      <dc:date>2022-04-04T22:00:00Z</dc:date>
    </item>
    <item>
      <title>The Bodenmiller group characterises chemokine expression and function in melanoma</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Multiplexed-imaging-mass-cytometry-of-the-chemokine-milieus-in-melanoma-characterizes-features-of-the-response-to-immunotherapy.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:b35ed463-95cd-4533-8189-2ced7a07d67a/Fig.jpeg" width="90" height="60" />
      <description><![CDATA[<p><strong>Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy</strong></p>

<p><br />
To predict the effects of immunotherapy in cancer, better spatial understanding of the tumor microenvironment (TME) is needed. In this work, the Bodenmiller group characterised chemokine expression and function in samples from 69 patients with metastatic melanoma. Using multiplexed mass cytometry-based imaging of protein markers and RNA transcripts, they found that CXCL9 and CXCL10 were present in patches with CXCL13+ exhausted T cells, suggesting that they recruited B cells and aided in the formation of tertiary lymphoid structures (TLS) in melanoma. TLS had a spatial enrichment of na&amp;iuml;ve and na&amp;iuml;ve-like T cells, which are involved in anti-tumor responses. Together, this study highlights the strength of targeted RNA and protein co-detection to analyse TME based on chemokine expression and suggests that the formation of tertiary lymphoid structures may be accompanied by na&amp;iuml;ve and na&amp;iuml;ve-like T cell recruitment, which may contribute to anti-tumor activity.</p>

<p>See Hoch, Schulz et al., <a href=&quot;https://www.science.org/doi/10.1126/sciimmunol.abk1692&quot;>Sci Immunol</a></p>]]></description>
      <pubDate>Thu, 31 Mar 2022 22:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Multiplexed-imaging-mass-cytometry-of-the-chemokine-milieus-in-melanoma-characterizes-features-of-the-response-to-immunotherapy.html</guid>
      <dc:date>2022-03-31T22:00:00Z</dc:date>
    </item>
    <item>
      <title>Magdalini Polymenidou receives an ERC Consolidator Grant</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Magdalini-Polymenidou-awarded-ERC-Consolidator-Grant.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:b989b19e-110c-4b11-a264-5ef342c76bbf/Magdalini%20Polymenidou%20ERC%20Consolidator%20Grant.png" width="90" height="60" />
      <description><![CDATA[<p>We congratulate <strong>Prof. Dr. Magdalini Polymenidou</strong>, who&amp;nbsp;has been awarded the prestigious&amp;nbsp;<strong><span class=&quot;attention&quot;>ERC Consolidator Grant</span></strong> for the&amp;nbsp;project &amp;ldquo;TDP-43 transitions&amp;rdquo;.&amp;nbsp;</p>

<p>Please have a look at the <a href=&quot;https://www.media.uzh.ch/en/Press-Releases/2022/ERC-Consolidator-Grants.html&quot;>UZH News</a> and &amp;nbsp;<a href=&quot;https://erc.europa.eu/news/erc-2021-consolidator-grants-results&quot;>ERC Announcement</a></p>

<p>&amp;nbsp;</p>]]></description>
      <pubDate>Wed, 16 Mar 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Magdalini-Polymenidou-awarded-ERC-Consolidator-Grant.html</guid>
      <dc:date>2022-03-16T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Menze group develops a deep neural network to reconstruct the 3D standing spine posture from 2D Radiographs</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Anatomy-Aware-Inference-of-the-3D-Standing-Spine-Posture-from-2D-Radiographs.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:f3a6f54a-0c97-4c01-9651-4ef1d31f52ab/tomography-08-00039-g010.png" width="90" height="60" />
      <description><![CDATA[<p><strong>Anatomy-Aware Inference of the 3D Standing Spine Posture from 2D Radiographs</strong></p>

<p>In various spinal disorders, a biomechanical load analysis of the spine in the upright position is useful to understand the underlying causes of the disorder and to help guide therapy. Despite the complex 3D shape of the human spine, this analysis is typically performed using 2D radiographs. Here, the Menze group proposes a novel&amp;nbsp;deep neural network architecture, which takes orthogonal 2D radiographs and infers the spine&amp;rsquo;s 3D posture using vertebral shape priors&amp;nbsp;to reconstruct the 3D spinal pose in an upright standing position.</p>

<p>See Bayat et al., <a href=&quot;https://www.mdpi.com/2379-139X/8/1/39&quot;>Tomography</a><br />
&amp;nbsp;</p>]]></description>
      <pubDate>Sun, 27 Feb 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Anatomy-Aware-Inference-of-the-3D-Standing-Spine-Posture-from-2D-Radiographs.html</guid>
      <dc:date>2022-02-27T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The Polymenidou group publishes a protocol for the identification of RNA–RBP interactions in subcellular compartments by CLIP-Seq</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Identification-of-RNA%E2%80%93RBP-Interactions-in-Subcellular-Compartments-by-CLIP-Seq.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:2dfa8cd0-f381-41ec-9210-b6a130e2e6f0/495486_1_En_19_Fig1_HTML.png" width="90" height="60" />
      <description><![CDATA[<p>Cross-linking immunoprecipitation and high-throughput sequencing (CLIP-seq) allows the identification of RNA bound by RNA-binding proteins (RBPs) <em>in vivo </em>and <em>ex vivo </em>with high specificity. In this protocol paper, the Polymenidou lab describe the adaptation of CLIP-seq to identify the specific RNA targets of an RBP (FUS) at neuronal synapses, including subcompartment isolation, RBP&amp;ndash;RNA complex enrichment, and upscaling steps.</p>

<p>See Sahadevan,&amp;nbsp;P&amp;eacute;rez-Berlanga &amp;&amp;nbsp;Polymenidou,<a href=&quot;https://link.springer.com/protocol/10.1007/978-1-0716-1975-9_19&quot;>Methods Mol. Biol.</a></p>]]></description>
      <pubDate>Thu, 17 Feb 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Identification-of-RNA%E2%80%93RBP-Interactions-in-Subcellular-Compartments-by-CLIP-Seq.html</guid>
      <dc:date>2022-02-17T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Zsolt Balázs (Krauthammer group) wins the Pfizer Research Prize 2022</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Zsolt-Bal%C3%A1zs-Pfizer-Forschungspreis.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:f4af85ee-a6e5-4954-a69f-98d69bb251d5/O_11_Zsolt%20Balazs_150.jpg" width="90" height="60" />
      <description><![CDATA[<p>We congratulate Dr. Zsolt Bal&amp;aacute;zs (Krauthammer group)&amp;nbsp;for winning the Pfizer Research Prize 2022 together with Dr.&amp;nbsp;Egle Ramelyte and Dr. Aizhan Tastanova (University Hospital Zurich)&amp;nbsp;for their single-cell RNA studies on the effects of oncolytic viral therapy in cutaneous lymphoma. (Ramelyte et al., <a href=&quot;https://www.sciencedirect.com/science/article/pii/S153561082030670X?via%3Dihub&quot;>Cancer Cell</a>).</p>

<p>Please find the full announcement here: <a href=&quot;https://www.pfizerforschungspreis.ch/de-ch/preistraegerinnen/projekt/einfluss-von-onkolytischen-viren-auf-die-zellfunktionen-bei-hautlymphom&quot;>Stiftung Pfizer Forschungspreis</a>&amp;nbsp;<br />
and the UZH News article <a href=&quot;https://www.news.uzh.ch/de/articles/2022/Forschungspreis_Pfizer.html&quot;>here</a>.<br />
&amp;nbsp;</p>]]></description>
      <pubDate>Wed, 09 Feb 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Zsolt-Bal%C3%A1zs-Pfizer-Forschungspreis.html</guid>
      <dc:date>2022-02-09T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Watch Bernd Bodenmiller&#039;s video on innovative research at the Comprehensive Cancer Center Zurich (german only)</title>
      <link>https://www.dqbm.uzh.ch/en/News-Archive/Bernd-Bodenmiller-Comprehensive-Cancer-Center-Zurich.html</link>
      <media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://www.dqbm.uzh.ch/dam/jcr:a506575e-25bc-4f66-a359-dabd34dc32a9/Screenshot%202022-02-07%20at%2008.18.45.png" width="90" height="60" />
      <description><![CDATA[<p><br />
In diesem <a href=&quot;https://www.youtube.com/watch?v=houyh79JNIw&amp;list=PLUpkq5x06ftovpPnjVutkcoRFM77CmSRy&amp;index=5&quot;>Video</a> erkl&amp;auml;rt Bernd Bodenmiller, wie die innovative Krebsforschung am Comprehensive Cancer Center Zurich (CCCZ) Krebspatientinnen und -patienten Zugang zu personalisierten Behandlungskonzepten erm&amp;ouml;glicht.</p>]]></description>
      <pubDate>Sun, 06 Feb 2022 23:00:00 GMT</pubDate>
      <guid>https://www.dqbm.uzh.ch/en/News-Archive/Bernd-Bodenmiller-Comprehensive-Cancer-Center-Zurich.html</guid>
      <dc:date>2022-02-06T23:00:00Z</dc:date>
    </item>
  </channel>
</rss>
